Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:636419.
doi: 10.1155/2012/636419. Epub 2012 Jun 24.

Oxidative damage, inflammation, and Toll-like receptor 4 pathway are increased in preeclamptic patients: a case-control study

Affiliations

Oxidative damage, inflammation, and Toll-like receptor 4 pathway are increased in preeclamptic patients: a case-control study

Fabiana C B Bernardi et al. Oxid Med Cell Longev. 2012.

Abstract

Problem: There was no direct correlation between plasma and placental oxidative damage parameters and inflammation and evidence of TLR4 pathway activation in the placenta in preeclamptic (PE) patients.

Method of study: 33 PE patients and 33 normotensive pregnant women were included. The maternal section of the placenta and blood were collected to the determination of oxidative damage markers (thiobarbituric acid reactive species and protein carbonyls), inflammatory response (interleukin-6 and myeloperoxidase activity), and activation of the TLR-4-NF-kB pathway.

Results: An increase of IL-6 levels in both plasma and placenta was observed, but myeloperoxidase activity was not significantly different comparing the groups. Oxidative damage parameters were increased in plasma and placenta in PE patients. A significant increase of the protein levels of TLR-4 and NF-kB was observed in the placenta.

Conclusion: The TLR4-NF-kB pathway is upregulated in PE, probably generating local and systemic inflammatory response that is followed by local and systemic oxidative damage.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Plasma and placenta levels of interleukin-6 in normal gestation and preeclamptic patients. 33 preeclamptic patients and 33 matched normotensive pregnant women were included and their placenta and peripheral venous blood samples were collected to the determination of interleukin-6 levels using ELISA. *Different from their respective control, P < 0.05. PE = pre-eclampsia.
Figure 2
Figure 2
Placenta activity of myeloperoxidase in normal gestation and preeclamptic patients.33 preeclamptic patients and 33 matched normotensive pregnant women were included and their placenta was collected to the determination of myeloperoxidase activity using colorimetric assay. PE: pre-eclampsia.
Figure 3
Figure 3
Plasma and placenta levels of thiobarbituric reactive acid species in normal gestation and preeclamptic patients. 33 preeclamptic patients and 33 matched normotensive pregnant women were included and their placenta and peripheral venous blood samples were collected to the determination of thiobarbituric reactive acid species using colorimetric assay. *Different from their respective control,  P < 0.05. PE: pre-eclampsia.
Figure 4
Figure 4
Plasma and placenta levels of protein carbonyls in normal gestation and preeclamptic patients. 33 preeclamptic patients and 33 matched normotensive pregnant women were included and their placenta and peripheral venous blood samples were collected to the determination of protein carbonyls using colorimetric assay. *Different from their respective control,  P < 0.05. PE = pre-eclampsia.
Figure 5
Figure 5
Placenta protein levels of Toll-like receptor 4, MyD-88 and Nuclear Factor-kB in normal gestation and preeclamptic patients. 33 preeclamptic patients and 33 matched normotensive pregnant women were included and their placenta was collected to the determination of protein levels of Toll-like receptor 4, MyD-88 and nuclear factor-kB using immunoblotting. *Different from their respective control,  P < 0.05. PE: pre-eclampsia.

Similar articles

Cited by

References

    1. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clinics in Perinatology. 1991;18(4):661–682. - PubMed
    1. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999;33(1 I):83–89. - PubMed
    1. Bernardi F, Guolo F, Bortolin T, Petronilho F, Dal-Pizzol F. Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. Journal of Obstetrics and Gynaecology Research. 2008;34(6):948–951. - PubMed
    1. Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta. 2005;26(1):53–58. - PubMed
    1. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. American Journal of Obstetrics and Gynecology. 1992;167(4 I):946–949. - PubMed

MeSH terms